Astrazeneca Pharma India Share Price

Small Cap | Pharmaceuticals and health care | NSE: ASTRAZEN | BSE: 506820

₹7,904.00 image-164.55 (-2.04 %)

Last Updated: 04 Apr 2025 03:52 PM

Technicalsimage BULLISHimage

Overview

Open (₹) 8,012.40

High (₹) 8,199.85

Low (₹) 7,857.05

Prev. Close (₹) 8,068.55

Volume 28,883

VWAP (₹) 6,737.67

ROCE (%) 28.34

Industry P/E 44.73

TTM P/E 203.76

P/B Ratio 27.76

Market Cap (₹) Cr.19,760.00

Dividend Yield (%)0.30

EPS (₹) 64.60

ROE22.68%

Sales Growth (%) 29.17

Profit Growth (%)62.66

Day Range

8,199.858,199.85

L
H

52 Week Range

5,000.009,049.95

L
H

Historical Returns

Returns (6M)

0.75 %

Returns (1Y)

53.57 %

Returns (3Y)

184.04 %

Returns (5Y)

193.43 %

Returns (6M)

0.75 %

Returns (1Y)

53.57 %

Returns (3Y)

184.04 %

Returns (5Y)

193.43 %

SWOT Analysis

  • Increasing Revenue every Quarter for the past 4 Quarters
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BULLISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 21.48

MFI 34.82

ATR 268.37

Commodity Channel Index -110.90

ROC125 0.56

ROC21 -7.77

Williams %R -97.19

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current6,875.107,051.557,154.106,772.556,596.106,493.556,317.10
Week Ago6,992.557,114.807,207.006,900.356,778.106,685.906,563.65
Month Ago7,191.047,332.077,517.597,005.526,864.496,678.976,537.94

EMA & SMA
info_icon

7904.00

Current Price

EMA & SMApin

Bullish Moving Averages

20

Bearish Moving Averages

0

5 Day 6859.85


9 Day 6930.18


10 Day 6961.64


12 Day 7106.30


14 Day 7146.54

20 Day 7233.09


26 Day 7172.41


50 Day 7012.14


100 Day 7068.00


200 Day 6824.35

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GRAVITON RESEARCH CAPITAL LLPbulkSell07 Oct, 2024₹7,887.161,25,166NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy07 Oct, 2024₹7,884.411,25,166NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell30 Sept, 2024₹7,804.961,27,119NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy30 Sept, 2024₹7,802.001,27,119NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell24 Sept, 2024₹7,506.361,31,308NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy24 Sept, 2024₹7,499.171,31,308NSE

Insider Trading

No insider trading details available.

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
27 May, 2024Rs.24.0000 per share(1200%)Dividend05 Jul, 202405 Jul, 2024
30 May, 2023Rs.16.0000 per share(800%)Dividend14 Jul, 202314 Jul, 2023
26 May, 2022Rs.8.0000 per share(400%)Final Dividend07 Jul, 202208 Jul, 2022

Announcements

DateSourceDetail
04 Apr, 2025BSE IndiaPlease find the enclosed intimation of the Company in relation to the captioned subject for your reference.
04 Apr, 2025BSE IndiaPlease find the enclosed intimation of the Company as per the captioned subject for your reference.
28 Mar, 2025NSE IndiaAstraZeneca Pharma India Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
28 Mar, 2025BSE IndiaPlease find the enclosed intimation of the Company in relation to the captioned subject for your reference.
28 Mar, 2025BSE IndiaPlease find the enclosed intimation of the Company as per the captioned subject for your reference.
28 Mar, 2025NSE IndiaAstraZeneca Pharma India Limited has informed the Exchange about General Updates
22 Mar, 2025NSE IndiaAstraZeneca Pharma India Limited has informed the Exchange regarding ''Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ''.
19 Mar, 2025NSE IndiaAstraZeneca Pharma India Limited has informed the Exchange regarding ''Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ''.
14 Mar, 2025NSE IndiaASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Closure of Trading Window
14 Mar, 2025NSE IndiaAstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--21 Jan, 202511 Feb, 2025
Quarterly Results--28 Oct, 202413 Nov, 2024
Quarterly Results--25 Jul, 202408 Aug, 2024
Audited Results & Dividend--16 May, 202427 May, 2024
Quarterly Results--30 Jan, 202408 Feb, 2024
Quarterly Results--31 Oct, 202309 Nov, 2023
Quarterly Results--07 Aug, 202314 Aug, 2023
Audited Results & Dividend--24 May, 202330 May, 2023
Quarterly Results--31 Jan, 202310 Feb, 2023
Quarterly Results--31 Oct, 202211 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group75%75%75%75%75%
Foreign Institutions +2.92%2.66%2.61%2.38%2.36%
Domestic Institutions +5.21%2.77%1.43%1.14%1.46%
Government0%0%0%0%0%
Public16.87%19.57%20.96%21.48%21.18%
Others0%0%0%0%0%

About Astrazeneca Pharma India

AstraZeneca Pharma India is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1295.53 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2024.

Parent Organisation

AstraZeneca Group

Founded

1979

Managing Director

-- --

NSE Symbol

ASTRAZEN

Astrazeneca Pharma India Management

NameDesignation
Mr. Narayan K SeshadriChairperson & Independent Director
Mr. Sanjeev Kumar PanchalExecutive Director
Ms. Bhavana AgrawalExecutive Director
Ms. Sylvia Lorena Varela RamonNon Executive Director
Ms. Hooi Bien ChuahNon Executive Director
Ms. Shilpa Divekar NirulaIndependent Director
Ms. Revathy AshokIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)
₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)
₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)
₹1,910.100 - ₹3,050.000

FAQs on Astrazeneca Pharma India

What is the share price of Astrazeneca Pharma India?

The share price of Astrazeneca Pharma India on 04 Apr, 2025 is ₹ 7,904.00.

What is 52W high and 52W low share price of Astrazeneca Pharma India?

The highest and lowest 52W share prices of Astrazeneca Pharma India are ₹ 9049.950 and ₹ 5000.000

What is the market cap of Astrazeneca Pharma India?

The market capitalization of Astrazeneca Pharma India as of 04 Apr, 2025 is ₹ 19,760.00 Crores

What is the P/E ratio of Astrazeneca Pharma India?

The current P/E ratio of Astrazeneca Pharma India as of 04 Apr, 2025 is 44.73

What is the PB ratio of Astrazeneca Pharma India?

The PB ratio of Astrazeneca Pharma India as of 04 Apr, 2025 is 27.76

Top Gainers

₹18.07image

₹15.14 (0.19%)

₹66.60image

₹57.80 (0.15%)

₹88.74image

₹73.95 (0.20%)

₹197.50image

₹167.35 (0.18%)

Top Losers

₹307.35image

₹368.55 (-0.17%)

₹108.20image

₹127.00 (-0.15%)

₹0.54image

₹1.03 (-0.48%)

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited